122 results on '"Ducassou, Stephane"'
Search Results
2. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
3. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
4. Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART
5. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
6. Orientation et prise en charge de la leucémie aiguë myéloïde néonatale : recommandations du comité leucémies de la SFCE
7. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus
8. Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS
9. The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
10. Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial
11. Risk factors in pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST): Results from the French Pediatric Oncology Society (SFCE) cohort
12. Développement des médicaments en pédiatrie : défis existants et recommandations
13. Paediatric drug development and evaluation: Existing challenges and recommendations
14. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias
15. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study
16. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety
17. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
18. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation
19. ATMgerm line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
20. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
21. Ovarian Function and Spontaneous Pregnancy After Hematopoietic Stem Cell Transplantation for Leukemia Before Puberty: An L.E.A. Cohort Study
22. Family history of cancer and the risk of childhood brain tumors : a pooled analysis of the ESCALE and ESTELLE studies (SFCE)
23. Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia
24. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
25. Childhood brain tumours, early infections and immune stimulation: A pooled analysis of the ESCALE and ESTELLE case-control studies (SFCE, France)
26. Maternal use of household pesticides during pregnancy and risk of neuroblastoma in offspring. A pooled analysis of the ESTELLE and ESCALE French studies (SFCE)
27. Parental smoking, maternal alcohol, coffee and tea consumption and the risk of childhood brain tumours : the ESTELLE and ESCALE studies (SFCE, France)
28. Abstract CT088: Phase I/II study of the PARP inhibitor olaparib in combination with irinotecan in children with advanced malignancies: arm D of the AcSé-ESMART trial
29. Cardiac and Vascular Risks Are the Essential Parameters for Long-Term Surveillance of Lower Risk Childhood Acute Leukemia Survivors
30. Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE Study
31. Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms
32. Securing access to innovative anticancer therapies for children, adolescents, and young adults outside clinical trials: The SACHA study of the French Society of Pediatric Oncology (SFCE).
33. Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms
34. Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)
35. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE Study (SFCE)
36. Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement
37. Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
38. Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children
39. A phase 2 study of nilotinib in pediatric patients with CML:Long-term update on growth retardation and safety
40. Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study
41. Chromothripsis and Genomic Complexity As Pejorative Prognostic Markers in Pediatric and Adult T-ALL
42. ATM Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia
43. Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia
44. NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients
45. Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases
46. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
47. Thymus and mediastinal node involvement in childhood langerhans cell histiocytosis: Long-term follow-up from the French national cohort
48. SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
49. Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia study
50. Tolerance to arsenic trioxide combined with all‐trans‐retinoic acid in children with acute promyelocytic leukaemia in France
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.